Rapid Micro Biosystems, Inc.
RPID · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $8 | $7 | $7 | $8 |
| % Growth | 7.9% | 0.8% | -12.3% | – |
| Cost of Goods Sold | $6 | $5 | $7 | $7 |
| Gross Profit | $2 | $2 | $0 | $1 |
| % Margin | 29% | 26.8% | 5.6% | 11.9% |
| R&D Expenses | $4 | $3 | $4 | $3 |
| G&A Expenses | $6 | $6 | $6 | $5 |
| SG&A Expenses | $9 | $9 | $8 | $8 |
| Sales & Mktg Exp. | $3 | $3 | $3 | $3 |
| Other Operating Expenses | $2 | $2 | $0 | $0 |
| Operating Expenses | $14 | $14 | $12 | $11 |
| Operating Income | -$11 | -$12 | -$12 | -$10 |
| % Margin | -145.1% | -167.3% | -161.8% | -124.5% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $1 |
| Pre-Tax Income | -$11 | -$12 | -$11 | -$10 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$12 | -$12 | -$11 | -$10 |
| % Margin | -146.8% | -163.3% | -156.3% | -117.6% |
| EPS | -0.25 | -0.27 | -0.26 | -0.22 |
| % Growth | 7.4% | -3.8% | -18.2% | – |
| EPS Diluted | -0.25 | -0.27 | -0.26 | -0.22 |
| Weighted Avg Shares Out | 45 | 45 | 44 | 44 |
| Weighted Avg Shares Out Dil | 45 | 45 | 44 | 44 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$10 | -$11 | -$11 | -$9 |
| % Margin | -131.1% | -152% | -150.1% | -113.9% |